All Updates

Barbara Behal recibió el premio Líder del Año del Equipo Constituyente de Embajadores (ACT) otorgado por la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) por su excepcional compromiso con la labor de defensa y por hacer del cáncer una prioridad nacional.

As Congress works to determine 2024 priorities before the budget deadline at the end of the month, nearly 700 cancer patients, survivors and their loved ones from all 50 states, Washington, D.C., Guam and Puerto Rico, and nearly every congressional district, will be on Capitol Hill this week to make clear to members of Congress that cancer must be a national priority.

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to the Centers for Medicare & Medicaid Services (CMS) offering recommendations that are unique to cancer to consider when implementing the negotiation provision of the Inflation Reduction Act.

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to the Centers for Medicare & Medicaid Services (CMS) offering recommendations that are unique to cancer to consider when implementing the negotiation provision of the Inflation Reduction Act.

Washington, D.C., September 14, 2023 – Bipartisan legislation that would eliminate financial barriers to prostate cancer screening was introduced in the U.S. Senate. Sponsored by Sens. Cory Booker (D-NJ) and John Boozman (R-AR), the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements for men with the highest risk of prostate cancer, focusing on Black men and those with a family history of the disease.

The California Legislature passed a bill to ensure that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing . Senate Bill 496, sponsored by ACS CAN and the University of California, now heads to the governor’s desk.

Washington, D.C., September 14, 2023 – Bipartisan legislation that would eliminate financial barriers to prostate cancer screening was introduced in the U.S. Senate. Sponsored by Sens. Cory Booker (D-NJ) and John Boozman (R-AR), the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements for men with the highest risk of prostate cancer, focusing on Black men and those with a family history of the disease.

The California Legislature passed a bill to ensure that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing . Senate Bill 496, sponsored by ACS CAN and the University of California, now heads to the governor’s desk.

The American Cancer Society Cancer Action Network (ACS CAN), ACS’ advocacy affiliate, continues to promote policies that expand sustainable access to patient navigation to better support cancer patients. As part of this effort, ACS CAN is urging CMS to finalize a proposed policy as part of a recent payment rule that would allow Medicare to implement a reimbursement strategy that will ensure payment for patient navigation services delivered by professionally trained and certified navigators. ACS CAN also joined with patient and provider groups in a second letter to emphasize the critical importance of navigation reimbursement to facilitating this critical service.